Ribophorin II promotes the epithelial–mesenchymal transition and aerobic glycolysis of laryngeal squamous cell carcinoma via regulating reactive oxygen species-mediated Phosphatidylinositol-3-Kinase/Protein Kinase B activation

References

• Genden EM, Ferlito A, Silver CE, et al. Evolution of the management of laryngeal cancer. Oral Oncol. 2007;43(5):431–439.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhang Y, Zheng X, et al. Circular RNA circCORO1C promotes laryngeal squamous cell carcinoma progression by modulating the let-7c-5p/PBX3 axis. Mol Cancer. 2020;19(1):99.
   PubMed Web of Science ®Google Scholar
• Steuer CE, El-Deiry M, Parks JR, et al. An update on larynx cancer. CA Cancer J Clin. 2017;67(1):31–50.
   PubMed Web of Science ®Google Scholar
• Honma K, Iwao-Koizumi K, Takeshita F, et al. RPN2 gene confers docetaxel resistance in breast cancer. Nat Med. 2008;14(9):939–948.
   PubMed Web of Science ®Google Scholar
• Takahashi RU, Takeshita F, Honma K, et al. Ribophorin II regulates breast tumor initiation and metastasis through the functional suppression of GSK3beta. Sci Rep. 2013;3:2474.
   PubMed Web of Science ®Google Scholar
• Li C, Ran H, Song S, et al. Overexpression of RPN2 suppresses radiosensitivity of glioma cells by activating STAT3 signal transduction. Mol Med. 2020;26(1):43.
   PubMed Web of Science ®Google Scholar
• Han C, Chen S, Ma H, et al. RPN2 predicts poor prognosis and promotes bladder cancer growth and metastasis via the PI3K-Akt pathway. Onco Targets Ther. 2021;14:1643–1657.
   PubMed Web of Science ®Google Scholar
• Ono M, Tsuda H, Kobayashi T, et al. The expression and clinical significance of ribophorin II (RPN2) in human breast cancer. Pathol Int. 2015;65(6):301–308.
   PubMed Web of Science ®Google Scholar
• Chen WS, Luo SD, Chiu TJ, et al. Ribophorin II overexpression is associated with poor response to induction chemotherapy with docetaxel, cisplatin, and fluorouracil in P16-negative locally advanced head and neck squamous cell carcinoma. J Clin Med. 2021;10(18):4118.
   PubMed Web of Science ®Google Scholar
• Lian M, Fang J, Han D, et al. Microarray gene expression analysis of tumorigenesis and regional lymph node metastasis in laryngeal squamous cell carcinoma. PloS one. 2013;8(12):e84854.
   PubMed Web of Science ®Google Scholar
• Vaupel P, Schmidberger H, Mayer A. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol. 2019;95(7):912–919.
   PubMed Web of Science ®Google Scholar
• Chang HC, Yang HL, Pan JH, et al. Hericium erinaceus inhibits TNF-alpha-induced angiogenesis and ROS generation through suppression of MMP-9/NF-kappaB signaling and activation of Nrf2-mediated antioxidant genes in human EA.hy926 endothelial cells. Oxid Med Cell Longev. 2016;2016:8257238.
   PubMed Web of Science ®Google Scholar
• Zeng K, Wang Z, Ohshima K, et al. BRAF V600E mutation correlates with suppressive tumor immune microenvironment and reduced disease-free survival in Langerhans cell histiocytosis. Oncoimmunology. 2016;5(7):e1185582.
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhang S, Chen Z, et al. CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1. Cell Death Dis. 2019;10(12):885.
   PubMedGoogle Scholar
• Sosa V, Moline T, Somoza R, et al. Oxidative stress and cancer: an overview. Ageing Res Rev. 2013;12(1):376–390.
   PubMed Web of Science ®Google Scholar
• Rodic S, Vincent MD. Reactive oxygen species (ROS) are a key determinant of cancer’s metabolic phenotype. Int J Cancer. 2018;142(3):440–448.
   PubMed Web of Science ®Google Scholar
• Huang JL, Cao SW, Ou QS, et al. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma. Mol Cancer. 2018;17(1):93.
   PubMedGoogle Scholar
• Gao T, Zhang X, Zhao J, et al. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1alpha pathway and Drp1-mediated mitochondrial fission in ovarian cancer. Cancer Lett. 2020;469:89–101.
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhu X, Wu H, et al. Targeting the ROS/PI3K/AKT/HIF-1alpha/HK2 axis of breast cancer cells: combined administration of Polydatin and 2-Deoxy-d-glucose. J Cell Mol Med. 2019;23(5):3711–3723.
   PubMed Web of Science ®Google Scholar
• Loffler C, Rao VV, Hansmann I. Mapping of the ribophorin II (RPN II) gene to human chromosome 20q12-q13.1 by in-situ hybridization. Hum Genet. 1991;87(2):221–222.
   PubMed Web of Science ®Google Scholar
• Bi C, Jiang B. Downregulation of RPN2 induces apoptosis and inhibits migration and invasion in colon carcinoma. Oncol Rep. 2018;40(1):283–293.
   PubMed Web of Science ®Google Scholar
• Tominaga N, Hagiwara K, Kosaka N, et al. RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy. Mol Cancer. 2014;13(1):134.
   PubMedGoogle Scholar
• Li Y, Huang C, and Bai Q, et al. Ribophorin II promotes cell proliferation, migration, and invasion in esophageal cancer cells in vitro and in vivo. Biosci Rep. 2019;39(5):BSR20182448 .
   PubMedGoogle Scholar
• Hong F, Li Y, Ni H, et al. Downregulation of ribophorin II suppresses tumor growth, migration, and invasion of nasopharyngeal carcinoma. Onco Targets Ther. 2018;11:3485–3494.
   PubMed Web of Science ®Google Scholar
• Gioacchini FM, Alicandri-Ciufelli M, Magliulo G, et al. The clinical relevance of Ki-67 expression in laryngeal squamous cell carcinoma. Europ Archiv Oto-Rhino-Laryngol. 2015;272(7):1569–1576.
   PubMed Web of Science ®Google Scholar
• Lu W, Kang Y. Epithelial-mesenchymal plasticity in cancer progression and metastasis. Dev Cell. 2019;49(3):361–374.
   PubMed Web of Science ®Google Scholar
• Lau HC, Shen Y, Huang Q, et al. Glycolysis related gene expression signature in predicting prognosis of laryngeal squamous cell carcinoma. Bioengineered. 2021;12(1):8738–8752.
   PubMed Web of Science ®Google Scholar
• Xu D, Jin J, Yu H, et al. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2. J Exp Clin Cancer Res. 2017;36(1):44.
   PubMedGoogle Scholar
• Qin W, Tian Y, Zhang J, et al. The double inhibition of PDK1 and STAT3-Y705 prevents liver metastasis in colorectal cancer. Sci Rep. 2019;9(1):12973.
   PubMedGoogle Scholar
• Wang J, Yang S, Ge W, et al. MiR-613 suppressed the laryngeal squamous cell carcinoma progression through regulating PDK1. J Cell Biochem. 2018;119(7):5118–5125.
   PubMed Web of Science ®Google Scholar
• Cai H, Li J, Zhang Y, et al. LDHA promotes oral squamous cell carcinoma progression through facilitating glycolysis and epithelial-mesenchymal transition. Front Oncol. 2019;9:1446.
   PubMed Web of Science ®Google Scholar
• Lian R, Lu B, Jiao L, et al. MiR-132 plays an oncogenic role in laryngeal squamous cell carcinoma by targeting FOXO1 and activating the PI3K/AKT pathway. Eur J Pharmacol. 2016;792:1–6.
   PubMed Web of Science ®Google Scholar
• Gao W, Guo H, Niu M, et al. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway. Mol Cancer. 2020;19(1):166.
   PubMed Web of Science ®Google Scholar
• Sun J, Ma Q, Li B, et al. RPN2 is targeted by miR-181c and mediates glioma progression and temozolomide sensitivity via the wnt/beta-catenin signaling pathway. Cell Death Dis. 2020;11(10):890.
   PubMed Web of Science ®Google Scholar
• Fujimoto D, Goi T, Koneri K, et al. RPN2 is effective biomarker to predict the outcome of combined chemotherapy docetaxel and cisplatin for advanced gastric cancer. Oncotarget. 2018;9(20):15208–15218.
   PubMedGoogle Scholar